to BioTechniques free email alert service to receive content updates.
Molecular Biology, Nucleic-acid technologies: PCR
RT² Profiler™ PCR Arrays for the Fluidigm BioMark system
Fluidigm Corporation and SABiosciences (a QIAGEN Company) have created over 100 pathway-focused gene expression RT² Profiler™ PCR arrays validated for real-time analysis on the Fluidigm BioMark System for Genetic Analysis.
These gene expression assays are specifically designed for the workflow of Fluidigm's integrated fluidic circuits (IFCs) and the BioMark system. Each reagent kit includes pre-aliquoted reagents and primers needed for synthesizing first-strand cDNA ready for preamplification and pathway-focused analysis. PCR Arrays contain enough reagent to run five 96.96 Dynamic Array chips. Customized panels are also available. PCR arrays come in a 96-well format.
 
This Product is made by:

Fluidigm develops, manufactures, and markets proprietary Integrated Fluidic Circuit (IFC) systems that significantly improve productivity in life science research. Fluidigm’s IFCs enable the simultaneous performance of thousands of sophisticated biochemical measurements in extremely minute volumes. These “integrated circuits for biology” are made possible by miniaturizing and integrating liquid handling components on a single microfluidic device (IFC). Fluidigm’s IFC systems, consisting of instrumentation, software and single-use IFCs, increase throughput, decrease costs and enhance sensitivity compared to conventional laboratory systems. Fluidigm products have not been cleared or approved by the Food and Drug Administration for use as a diagnostic and are only available for research use.

Fluidigm Corporation
7000 Shoreline Court, Suite 100
South San Francisco, CA 94080
Phone: 1-866-358-4354
Fax: 650-871-7152
http://www.fluidigm.com